PLK1 maintains DNA methylation and cell viability by regulating phosphorylation-dependent UHRF1 protein stability

被引:0
|
作者
Yuchong Peng
Youhong Liu
Rirong Zheng
Yubing Ye
Yongming Fu
Linglong Yin
Yingxue Gao
Yuxin Fu
Xuli Qi
Tanggang Deng
Songwei Zhang
Xiong Li
机构
[1] Guangdong Pharmaceutical University,Key Laboratory of Clinical Precision Pharmacy of Guangdong Higher Education Institutes, The First Affiliated Hospital
[2] Guangdong Pharmaceutical University,Key Specialty of Clinical Pharmacy, The First Affiliated Hospital
[3] Guangdong Pharmaceutical University,NMPA Key Laboratory for Technology Research and Evaluation of Pharmacovigilance
[4] Central South University,Department of Oncology, Center for Molecular Medicine, Xiangya Hospital
[5] Central South University,Hunan Key Laboratory of Molecular Radiation Oncology, Xiangya Hospital
[6] Guangdong Pharmaceutical University,School of Pharmacy
[7] Guangdong Pharmaceutical University,School of Basic Medical Sciences
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
PLK1 is a key serine/threonine kinase as well as a master mitotic regulator, but it has never been reported that PLK1 regulates DNA methylation. In the present study, we for the first time found that PLK1 inhibition disrupted global DNA methylation and elevated the expression level of tumor suppressor genes. Mechanistically, we found that PLK1 interacts UHRF1 protein to induce its phosphorylation at serine 265. Phosphorylation is required for the maintenance of UHRF1 protein stability by recruiting a deubiquitinase USP7. Conversely, PLK1 inhibition decreases UHRF1 protein interaction with USP7 and activates the ubiquitin-proteasome pathway, thereby accelerating UHRF1 protein degradation. UHRF1 degradation decreases the recruitment of DNMT1 to chromatin, and decreases the level of genome-wide DNA methylation, thereby elevating the expression of tumor suppressor genes and decreasing cell viability. We here presented the first report on the novel role of PLK1 in DNA methylation maintenance through UHRF1-DNMT1 pathway, and revealed a novel anticancer mechanism of PLK1 inhibitors.
引用
收藏
相关论文
共 50 条
  • [21] Mechanistic insights into UHRF1-mediated DNA methylation by structure-based functional clarification of UHRF1 domains (Review)
    Song, Yiying
    Liu, Haiting
    Xian, Qingqing
    Gui, Chengzhi
    Xu, Mingjie
    Zhou, Yunying
    ONCOLOGY LETTERS, 2023, 26 (06)
  • [22] Plk1 Phosphorylation of Mre11 Antagonizes the DNA Damage Response
    Li, Zhiguo
    Li, Jie
    Kong, Yifan
    Yan, Shan
    Ahmad, Nihal
    Liu, Xiaoqi
    CANCER RESEARCH, 2017, 77 (12) : 3169 - 3180
  • [23] Polo-like kinase 1 (PLK1)-dependent phosphorylation of methylenetetrahydrofolate reductase (MTHFR) regulates replication via histone methylation
    Li, Xueyan
    Nai, Shanshan
    Ding, Yuehe
    Geng, Qizhi
    Zhu, Bingtao
    Yu, Kai
    Zhu, Wei-Guo
    Dong, Meng-Qiu
    Su, Xiao-Dong
    Xu, Xingzhi
    Li, Jing
    CELL CYCLE, 2017, 16 (20) : 1933 - 1942
  • [24] SET8 prevents excessive DNA methylation by methylation-mediated degradation of UHRF1 and DNMT1
    Zhang, Huifang
    Gao, Qinqin
    Tan, Shuo
    You, Jia
    Lyu, Cong
    Zhang, Yunpeng
    Han, Mengmeng
    Chen, Zhaosu
    Li, Jialun
    Wang, Hailin
    Liao, Lujian
    Qin, Jun
    Li, Jiwen
    Wong, Jiemin
    NUCLEIC ACIDS RESEARCH, 2019, 47 (17) : 9053 - 9068
  • [25] Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis
    Zhang, Yanquan
    Fong, Ka-Wing
    Mao, Fengyi
    Wang, Ruixin
    Allison, Derek B.
    Napier, Dana
    He, Daheng
    Liu, Jinpeng
    Zhang, Yeqing
    Chen, Jing
    Kong, Yifan
    Li, Chaohao
    Li, Guangbing
    Liu, Jinghui
    Li, Zhiguo
    Zhu, Haining
    Wang, Chi
    Liu, Xiaoqi
    CELL REPORTS, 2024, 43 (07):
  • [26] Non-canonical functions of UHRF1 maintain DNA methylation homeostasis in cancer cells
    Yamaguchi, Kosuke
    Chen, Xiaoying
    Rodgers, Brianna
    Miura, Fumihito
    Bashtrykov, Pavel
    Bonhomme, Frederic
    Salinas-Luypaert, Catalina
    Haxholli, Deis
    Gutekunst, Nicole
    Aygenli, Bihter Ozdemir
    Ferry, Laure
    Kirsh, Olivier
    Laisne, Marthe
    Scelfo, Andrea
    Ugur, Enes
    Arimondo, Paola B.
    Leonhardt, Heinrich
    Kanemaki, Masato T.
    Bartke, Till
    Fachinetti, Daniele
    Jeltsch, Albert
    Ito, Takashi
    Defossez, Pierre-Antoine
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [27] A role for LSH in facilitating DNA methylation by DNMT1 through enhancing UHRF1 chromatin association
    Han, Mengmeng
    Li, Jialun
    Cao, Yaqiang
    Huang, Yuanyong
    Li, Wen
    Zhu, Haijun
    Zhao, Qian
    Han, Jing-Dong Jackie
    Wu, Qihan
    Li, Jiwen
    Feng, Jing
    Wong, Jiemin
    NUCLEIC ACIDS RESEARCH, 2020, 48 (21) : 12116 - 12134
  • [28] UHRF1 Links the Histone Code and DNA Methylation to Ensure Faithful Epigenetic Memory Inheritance
    Bronner, Christian
    Fuhrmann, Guy
    Chedin, Frederic L.
    Macaluso, Marcella
    Dhe-Paganon, Sirano
    GENETICS & EPIGENETICS, 2009, 2 : 29 - 36
  • [29] Defining UHRF1 domains that support maintenance of human colon cancer DNA methylation and tumorigenicity
    Kong, Xiangqian
    Chen, Jie
    Xie, Wenbing
    Brown, Stephen M.
    Cai, Yi
    Wu, Kaichun
    Fan, Daiming
    Nie, Yongzhan
    Tao, Yong
    Yen, Ray-Whay Chiu
    Easwaran, Hariharan
    Topper, Michael J.
    Rothbart, Scott B.
    Xia, Limin
    Baylin, Stephen B.
    CANCER RESEARCH, 2019, 79 (13)
  • [30] Non-canonical functions of UHRF1 maintain DNA methylation homeostasis in cancer cells
    Kosuke Yamaguchi
    Xiaoying Chen
    Brianna Rodgers
    Fumihito Miura
    Pavel Bashtrykov
    Frédéric Bonhomme
    Catalina Salinas-Luypaert
    Deis Haxholli
    Nicole Gutekunst
    Bihter Özdemir Aygenli
    Laure Ferry
    Olivier Kirsh
    Marthe Laisné
    Andrea Scelfo
    Enes Ugur
    Paola B. Arimondo
    Heinrich Leonhardt
    Masato T. Kanemaki
    Till Bartke
    Daniele Fachinetti
    Albert Jeltsch
    Takashi Ito
    Pierre-Antoine Defossez
    Nature Communications, 15